HOME Top Market Reports Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

By: marketsandmarkets.com
Publishing Date: November 2015
Report Code: MD 2521

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020.

In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.

On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the market in 2015.

Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period.

The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMιrieux SA (France), and Cepheid Inc. (U.S.).

Scope of the Report

This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020.

Years Considered for the Study


Particular

Scope

Historical Year

2013

Base Year

2014

Estimated Year

2015

Projected Year

2020

Forecast Period

2015–2020

Revenue Currency

USD

Market Segmentation

Molecular Diagnostics Market, by Products and Services

  • Instruments
  • Reagents
  • Services & Software

Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
  • DNA Sequencing and Next-generation Sequencing
  • Microarrays
  • Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Genetics
  • Blood Screening
  • Microbiology
  • Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

Molecular Diagnostics Market, by End User

  • Reference Laboratories
  • Hospital Laboratories
  • Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • India
    • China
    • Rest of Asia (RoA)
  • Rest of the World (RoW)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
    • Pacific Countries
    • Middle East & Africa

Table of Contents

1 Introduction (Page No. - 25)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 29)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions

3 Executive Summary (Page No. - 37)

4 Premium Insights (Page No. - 43)
    4.1 Molecular Diagnostics Market
    4.2 Market,Infectious Diseases
    4.3 Market, By Technology and Application
    4.4 Market, By End User
    4.5 Market, By Products and Services

5 Market Overview (Page No. - 47)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence Rate of Infectious Diseases and Various Types of Cancer
                    5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
                    5.2.1.3 Development of Biomarker Identification and Advancements in Molecular Techniques
                    5.2.1.4 Growth in Proteomics and Genomics Research
                    5.2.1.5 Reforms in the Reimbursement System in the U.S.
           5.2.2 Restraints
                    5.2.2.1 Molecular Diagnostic Tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
                    5.2.2.2 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
           5.2.3 Opportunities
                    5.2.3.1 Advances in Genomics
                    5.2.3.2 Significant Growth Prospects in Developing Countries
           5.2.4 Challenge
                    5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application (Page No. - 56)
    6.1 Introduction
    6.2 Infectious Diseases
           6.2.1 Hepatitis B
           6.2.2 Hepatitis C
           6.2.3 Human Immunodeficiency Virus (HIV)
           6.2.4 Tuberculosis (TB)
           6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
           6.2.6 Human Papillomavirus (HPV)
           6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
           6.2.8 Others
    6.3 Oncology
           6.3.1 Prostate Cancer
           6.3.2 Breast Cancer
    6.4 Colorectal Cancer
    6.5 Others
    6.6 Genetic Tests
    6.7 Blood Screening
    6.8 Microbiology
    6.9 Others

7 Molecular Diagnostics Market, By Technology (Page No. - 87)
    7.1 Introduction
    7.2 Polymerase Chain Reaction (PCR)
    7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
    7.4 Microarrays
    7.5 Hybridization (In-Situ Hybridization & Fish)
    7.6 DNA Sequencing and Next-Generation Sequencing
    7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services (Page No. - 110)
    8.1 Introduction
    8.2 Reagents
    8.3 Instruments
    8.4 Software & Services

9 Molecular Diagnostics Market, By End User (Page No. - 124)
    9.1 Introduction
    9.2 Hospital/Academic Laboratories
    9.3 Reference Laboratories
    9.4 Other End Users

10 Molecular Diagnostic Market, By Region (Page No. - 136)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 U.K.
             10.3.2 Germany
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 Japan
             10.4.2 India
             10.4.3 China
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
                    10.5.1.1 Mexico
                    10.5.1.2 Brazil
                    10.5.1.3 Rest of Latin America (RoLA)
             10.5.2 Pacific Countries
             10.5.3 Middle East & Africa

11 Competitive Landscape (Page No. - 192)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Molecular Diagnostics Market Competitor Share Analysis, By Application
             11.3.1 Market Share Analysis for Infectious Disease Diagnostics Applications
             11.3.2 Market Share Analysis for Blood Screening Applications
             11.3.3 Market Share Analysis for Microbiology Applications
             11.3.4 Market Share Analysis for Oncology Applications
             11.3.5 Market Share Analysis for Genetic Testing Applications
     11.4 Molecular Diagnostics Market Share Analysis, By Technology
             11.4.1 Polymerase Chain Reaction (PCR)
             11.4.2 DNA Sequencing and Ngs
             11.4.3 Microarray
             11.4.4 Hybridization (In Situ and Fluorescence)
             11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
     11.5 Product Approvals
     11.6 Agreements, Collaborations, and Partnerships
     11.7 New Product Launches
     11.8 Acquisitions
     11.9 Other Developments

12 Company Profiles (Page No. - 208)
     12.1 Introduction
     12.2 Abbott Laboratories
             12.2.1 Business Overview
             12.2.2 Abbott Laboratories: Company Snapshot
             12.2.3 Products Offered
             12.2.4 Recent Developments
             12.2.5 MnM View
     12.3 Qiagen N.V.
             12.3.1 Business Overview
             12.3.2 Qiagen N.V.: Company Snapshot
             12.3.3 Products & Services Offered
             12.3.4 Recent Developments
             12.3.5 MnM View
     12.4 Roche Diagnostics
             12.4.1 Business Overview
             12.4.2 Roche Diagnostics: Company Snapshot
             12.4.3 Products Offered
             12.4.4 Recent Developments
             12.4.5 MnM View
     12.5 Hologic, Inc.
             12.5.1 Business Overview
             12.5.2 Hologic, Inc.: Company Snapshot
             12.5.3 Products Offered
             12.5.4 Recent Developments
             12.5.5 MnM View
     12.6 Grifols
             12.6.1 Business Overview
             12.6.2 Grifols: Company Snapshot
             12.6.3 Products Offered
             12.6.4 Recent Developments
             12.6.5 MnM View
     12.7 Siemens Healthcare
             12.7.1 Business Overview
             12.7.2 Siemens Healthcare: Company Snapshot
             12.7.3 Products Offered
             12.7.4 Recent Developments
     12.8 Becton, Dickinson and Company
             12.8.1 Business Overview
             12.8.2 Becton, Dickinson and Company: Company Snapshot
             12.8.3 Products & Services Offered
             12.8.4 Recent Developments
     12.9 Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)
             12.9.1 Business Overview
             12.9.2 Danaher Corporation: Company Snapshot
             12.9.3 Products & Services Offered
             12.9.4 Recent Developments
     12.10 Biomιrieux SA
             12.10.1 Business Overview
             12.10.2 Biomιrieux: Company Snapshot
             12.10.3 Products Offered
             12.10.4 Recent Developments
     12.11 Cepheid Inc.
             12.11.1 Business Overview
             12.11.2 Cepheid Inc.: Company Snapshot
             12.11.3 Products Offered
             12.11.4 Recent Developments

13 Appendix (Page No. - 263)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
             13.3.1 Abbott Laboratories
             13.3.2 Qiagen N.V.
             13.3.3 Roche Diagnostics
             13.3.4 Hologic Inc.
             13.3.5 Hologic Inc.
             13.3.6 Siemens Healthcare
             13.3.7 Becton, Dickinson and Company
             13.3.8 Becton, Dickinson and Company
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports


List of Tables (241 Tables)

Table 1 High Prevalence of Infectious Diseases & Cancer and Growth in Genomics Research to Drive the Molecular Diagnostics Market
Table 2 Requirement of Highly Skilled Labor and Complex Regulatory Framework Restraining Market Growth
Table 3 Developing Countries Provide Significant  Growth Opportunities for the Molecular Diagnostic Market
Table 4 Dearth of Trained Professionals is Limiting the Appropriate Use of New Molecular Diagnostic Technologies
Table 5 Molecular Diagnostic Market Size, By Application, 2015–2020 (USD Million)
Table 6 Application
Table 7 Infectious Disease Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 8 North America: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 9 Country
Table 10 Europe: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 11 Country/Region
Table 12 Asia: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 13 RoW: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 14 Country/Region
Table 15 Latin America: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 16 Country/Region
Table 17 Infectious Diseases Diagnostics Market Size, By Therapeutic Area, 2015–2020 (USD Million)
Table 18 Therapeutic Area
Table 19 Hepatitis B Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 20 Hepatitis B Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 21 Hepatitis C Market Size, By Region, 2015–2020 (USD Million)
Table 22 Hepatitis C Market Size, By Region, 2015–2020 (Million Assays)
Table 23 HIV Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 24 Hepatitis C Market Size, By Region, 2015–2020 (Million Assays)
Table 25 TB Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 26 TB Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 27 CT/NG Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 28 CT/NG Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 29 HPV Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 30 HPV Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 31 MRSA Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 32 MRSA Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 33 Other Infectious Disease Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 34 Oncology Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 35 North America: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 36 Europe: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 37 Asia: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 38 RoW: Oncology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 39 Latin America: Oncology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 40 Oncology Diagnostics Market Size, By Type, 2015–2020 (USD Million)
Table 41 Oncology Molecular Diagnostics Market Size, By Biomarker, 2015–2020 (Million Assays)
Table 42 Prostate Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 43 Breast Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 44 Colorectal Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 45 Other Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 46 Genetic Tests Market Size, By Region, 2015–2020 (USD Million)
Table 47 North America: Genetics Tests Market Size, By Country, 2015–2020 (USD Million)
Table 48 Europe: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 49 Asia: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 50 RoW: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 51 Latin America: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 52 Blood Screening Market Size, By Region, 2015–2020 (USD Million)
Table 53 North America: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 54 Europe: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 55 Asia: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 56 RoW: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 57 Latin America: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 58 Microbiology Molecular Diagnostic Market Size, By Region, 2015–2020 (USD Million)
Table 59 North America: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 60 Europe: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 61 Asia: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 62 RoW: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 63 Latin America: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 64 Other Molecular Diagnostic Applications Market Size, By Region, 2015–2020 (USD Million)
Table 65 North America: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 66 Europe: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 67 Asia: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 68 RoW: Other Molecular Diagnostics Applications Market Size, By Country, 2015–2020 (USD Million)
Table 69 Latin America: Other Molecular Diagnostics Applications Market Size, By Country, 2015–2020 (USD Million)
Table 70 Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 71 Molecular Diagnostic Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 72 North America: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 73 Europe: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 74 Asia: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 75 RoW: Molecular Diagnostic Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 76 Latin America: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 77 Molecular Diagnostic Market Size for INAAT, By Region, 2013–2020 (USD Million)
Table 78 North America: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 79 Europe: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 80 Asia: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 81 RoW: Molecular Diagnostic Market Size for INAAT, By Region, 2013–2020 (USD Million)
Table 82 Latin America: Molecular Diagnostics Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 83 Molecular Diagnostics Market Size for Microarrays, By Region, 2013–2020 (USD Million)
Table 84 North America: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 85 Europe: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 86 Asia: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 87 RoW: Molecular Diagnostics Market Size for Microarrays, By Region, 2013–2020 (USD Million)
Table 88 Latin America: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 89 Molecular Diagnostics Market Size for Hybridization, By Region, 2013–2020 (USD Million)
Table 90 North America: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 91 Europe: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 92 Asia: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 93 RoW: Molecular Diagnostics Market Size for Hybridization, By Region, 2013–2020 (USD Million)
Table 94 Latin America: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 95 Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Region, 2013–2020 (USD Million)
Table 96 North America: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 97 Europe: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 98 Asia: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 99 RoW: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Region, 2013–2020 (USD Million)
Table 100 Latin America: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 101 Molecular Diagnostics Market Size for Other Technologies, By Region, 2013–2020 (USD Million)
Table 102 North America: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 103 Europe: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 104 Asia: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 105 RoW: Molecular Diagnostics Market Size for Other Technologies, By Region, 2013–2020 (USD Million)
Table 106 Latin America: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 107 Molecular Diagnostics Market Size, By Products & Services, 2015–2020 (USD Million)
Table 108 Product/Service
Table 109 Molecular Diagnostic Reagents Market Size, By Region, 2015–2020 (USD Million)
Table 110 Molecular Diagnostic Reagents Market Size, By Technology, 2015–2020 (USD Million)
Table 111 North America: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 112 Europe: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 113 Asia: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 114 RoW: Molecular Diagnostic Reagents Market Size, By Region, 2015–2020 (USD Million)
Table 115 Latin America: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 116 Molecular Diagnostic Instruments Market Size, By Region, 2015–2020 (USD Million)
Table 117 Molecular Diagnostic Instruments Market Size, By Technology, 2015–2020 (USD Million)
Table 118 North America: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 119 Europe: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 120 Asia: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 121 RoW: Molecular Diagnostic Instruments Market Size, By Region, 2015–2020 (USD Million)
Table 122 Latin America: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 123 Molecular Diagnostic Software & Services Market Size, By Region, 2015–2020 (USD Million)
Table 124 North America: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 125 Europe: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 126 Asia: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 127 RoW: Molecular Diagnostic Software & Services Market Size, By Region, 2015–2020 (USD Million)
Table 128 Latin America: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 129 Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 130 Market Size for Hospital/Academic Laboratories, By Region, 2013–2020 (USD Million)
Table 131 North America: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 132 Europe: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 133 Asia: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 134 RoW: Market Size for Hospital/Academic Laboratories, By Region, 2013–2020 (USD Million)
Table 135 Latin America: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 136 Market Size for Reference Laboratories, By Region, 2013–2020 (USD Million)
Table 137 North America: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 138 Europe: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 139 Asia: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 140 RoW: Market Size for Reference Laboratories, By Region, 2013–2020 (USD Million)
Table 141 Latin America: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 142 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 143 North America: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 144 Europe: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 145 Asia: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 146 RoW: Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 147 Latin America: Market Size for Other End Users Laboratories, By Country, 2013–2020 (USD Million)
Table 148 Market Size, By Region, 2013–2020 (USD Million)
Table 149 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 150 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 151 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 152 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 153 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 154 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 155 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 156 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 157 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 158 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 159 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 160 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 161 Europe: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 162 Europe: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 163 Europe: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 164 Europe: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 165 U.K.: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 166 U.K.: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 167 U.K.: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 168 U.K.: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 169 Germany: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 170 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 171 Germany: Market Size, By Product, 2013–2020 (USD Million)
Table 172 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 173 France: Market Size, By Technology, 2013–2020 (USD Million)
Table 174 France: Market Size, By Application, 2013–2020 (USD Million)
Table 175 France: Market Size, By Product, 2013–2020 (USD Million)
Table 176 France: Market Size, By End User, 2013–2020 (USD Million)
Table 177 Italy: Market Size, By Technology, 2013–2020 (USD Million)
Table 178 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 179 Italy: Market Size, By Product, 2013–2020 (USD Million)
Table 180 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 181 Spain: Market Size, By Technology, 2013–2020 (USD Million)
Table 182 Spain: Market Size, By Application, 2013–2020 (USD Million)
Table 183 Spain: Market Size, By Product, 2013–2020 (USD Million)
Table 184 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 185 RoE: Market Size, By Technology, 2013–2020 (USD Million)
Table 186 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 187 RoE: Market Size, By Product, 2013–2020 (USD Million)
Table 188 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 189 Asia: Market Size, By Technology, 2013–2020 (USD Million)
Table 190 Asia: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 191 Asia: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 192 Asia: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 193 Japan: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 194 Japan: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 195 Japan: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 196 Japan: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 197 India: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 198 India: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 199 India: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 200 India: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 201 China: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 202 China: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 203 China: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 204 China: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 205 RoA: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 206 RoA: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 207 RoA: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 208 RoA: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 209 RoW: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 210 RoW: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 211 RoW: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 212 RoW: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 213 Latin America: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 214 Latin America: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 215 Latin America: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 216 Latin America: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 217 Mexico: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 218 Mexico: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 219 Mexico: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 220 Mexico: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 221 Brazil: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 222 Brazil: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 223 Brazil: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 224 Brazil: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 225 RoLA: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 226 RoLA: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 227 RoLA: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 228 RoLA: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 229 Pacific Countries: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 230 Pacific Countries: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 231 Pacific Countries: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 232 Pacific Countries: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 233 Middle East & Africa: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 234 Middle East & Africa: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 235 Middle East & Africa: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 236 Middle East & Africa: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 237 Product Approvals, 2012–2015
Table 238 Agreements, Collaborations, and Partnerships, 2012–2015
Table 239 New Product Launches, 2012–2015
Table 240 Acquisitions, 2012–2015
Table 241 Other Developments, 2012–2015


List of Figures (61 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Molecular Diagnostics Market Snapshot (2015 vs 2020)
Figure 5 Reagents to Account for the Largest Share of Molecular Diagnostics Market During the Forecast Period.
Figure 6 Hospital & Academic Laboratories to Lead the Market During the Forecast Period
Figure 7 Infectious Diseases Segment Will Continue to Dominate the Molecular Diagnostics Market During the Forecast Period
Figure 8 Microarray Segment Poised to Witness the Highest Growth Rate From 2015 to 2020
Figure 9 Product Approvals is the Dominant Strategy Among Market Players
Figure 10 Rising Prevalence of Infectious Diseases & Cancer to Drive Market Growth
Figure 11 MRSA Will Be the Fastest-Growing Segment During the Forecast Period
Figure 12 Infectious Diseases Segment Dominates the Molecular Diagnostics Market in 2015
Figure 13 Hospital & Academic Laboratories to Dominate the Molecular Diagnostics Market By 2020
Figure 14 Reagents Segment to Grow at the Highest CAGR During the Forecast Period
Figure 15 Molecular Diagnostics Market: Drivers, Restraints, Opportunities, and Threats
Figure 16 Infectious Disease Diagnostics, the Largest Segment of the Market in 2015
Figure 17 MRSA Diagnostics Holds Highest Growth Potential in the Molecular Diagnostics Market for Infectious Diseases in 2015
Figure 18 North America Will Continue to Lead in Oncology Molecular Diagnostics Market in Forecast Period
Figure 19 EGFR Assay Segment (By Volume) Will Grow at the Highest Pace During the Forecast Period
Figure 20 North America Will Continue to Dominate Genetics Tests Market During the Forecast Period
Figure 21 Asia is the Fastest-Growing Market for Other Applications
Figure 22 PCR to Dominate the Molecular Diagnostic Technologies Market During the Forecast Period
Figure 23 North America to Dominate the PCR Technology Market During the Forecast Period
Figure 24 Asia to Grow at Highest Rate  for the INAAT Technology Market During the Forecast Period
Figure 25 North America to Dominate the Microarrays Market During the Forecast Period
Figure 26 North America to Dominate the DNA Sequencing and Next-Generation Sequencing Market During the Forecast Period
Figure 27 North America to Dominate the Other Technologies Market During the Forecast Period
Figure 28 Reagents to Form the Largest Segment of the Molecular Diagnostics Market in 2015
Figure 29 Molecular Diagnostic Reagents Market in Asia to Grow at Highest Rate in 2015
Figure 30 North America to Command the Largest Share of the Molecular Diagnostic Instruments Market in 2015
Figure 31 Molecular Diagnostics Software & Services Market in Asia to Grow at the Highest Rate
Figure 32 Hospital/Academic Laboratories, the Major End Users of the Molecular Diagnostics Market
Figure 33 North America to Continue to Dominate the Hospital/Academic Laboratories Market During the Forecast Period
Figure 34 Asia: Highest Growth Potential in the Reference Laboratories End-User Market Segment
Figure 35 Germany is the Largest and Fastest-Growing Market for Reference Laboratories
Figure 36 North America is Expected to Be the Largest Regional Segment in the Molecular Diagnostics Market for Other End Users
Figure 37 Asia-Pacific Will Be the Fastest-Growing Region in the Molecular Diagnostics Market
Figure 38 Asian Market for Molecular Diagnostics Products Shows Significant Growth Opportunities
Figure 39  North America Will Continue to Lead the Global Molecular Diagnostics Market in the Forecast Period
Figure 40 North America Molecular Diagnostics Market Snapshot
Figure 41 PCR Technology Segment Will Continue to Lead the North American Market
Figure 42 Microarray Technology Segment is Growing at the Fastest Rate During the Forecast Period
Figure 43 Reagent Segment Will Continue to Dominate Molecular Diagnostics Market in Asia
Figure 44 Hospital/Academic Laboratories Dominate Molecular Diagnostics End-User Market in Japan
Figure 45 Latin America Will Continue to Lead the Molecular Diagnostics Market in RoW
Figure 46 Infectious Disease Will Be the Largest Application Segment of the Molecular Diagnostics Market in RoW
Figure 47 Brazil to Command Largest Share of Latin American Molecular Diagnostics Market in 2015
Figure 48 Product Innovation and Agreements, Collaborations, and Partnerships Were Key Strategies Adopted in the Last Three Years
Figure 49 Global Molecular Diagnostics Market Share, By Key Player, 2014
Figure 50 Global Infectious Disease Diagnostics Market Share, By Key Player, 2014
Figure 51 Global Blood Screening Market Share, By Key Player, 2014
Figure 52 Global Microbiology Market Share, By Key Player, 2014
Figure 53 Global Oncology MDX Diagnostics Market Share, By Key Player, 2014
Figure 54 Global Genetic Testing MDX Diagnostics Market Share, By Key Player, 2014
Figure 55 Global Molecular Diagnostics Market for PCR, Market Share Analysis, By Key Player, 2014 (%)
Figure 56 Global Molecular Diagnostics Market for DNA Sequencing and Ngs, Market Share Analysis, By Key Player, 2014 (%)
Figure 57 Global Molecular Diagnostics Market for Microarray, Market Share Analysis, By Key Player, 2014 (%)
Figure 58 Global Molecular Diagnostics Market for Hybridization, Market Share Analysis, By Key Player, 2014 (%)
Figure 59 Global Molecular Diagnostics Market for INAAT, Market Share Analysis, By Key Player, 2014 (%)
Figure 60 Battle for Market Share: Product Approvals and Agreements, Collaborations, and Partnerships Were Key Strategies
Figure 61 Geographic Revenue Mix of the Top Five Market Players

The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market. The molecular diagnostics market is broadly segmented on the basis of technology, application, products & services, and end user. The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing and next generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is categorized into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.

On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the market in 2015.

Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is poised to grow at the highest CAGR during the forecast period.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMιrieux SA (France), and Cepheid Inc. (U.S.).

Molecular Diagnostics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports